World of DTC Marketing

JANUARY 24, 2022

The amount of money required to gain approval of a new drug has been hotly debated, but it also costs a hell of a lot of money to launch a drug in today’s market. A study in 2020 estimated that the median cost of getting a new drug into the market was $985 million, and the average price was $1.3 Only about $2.2

Life Science 225

Life Science Drugs Development Genetic Disease 225

Pharmaceutical Technology

MAY 2, 2023

ODAIA, a life sciences predictive analytics and commercial insights provider, has secured an investment of $25m in its Series B funding round. This software-as-a-service (SaaS) platform is also used by life science brands to launch their drugs, therapeutics and vaccines in the markets, using data-driven solution.

Life Science 147

Life Science Branding Pharma Companies Production 147

pharmaphorum

SEPTEMBER 15, 2020

As pharmaceutical marketers prepare their brands for the future, there are a number of important ways they can learn from digitally-native brands. This is reinforced by web-focused marketing strategies that give them a highly-targeted approach when it comes to marketing execution.”. Be more agile .

Branding 130

Branding Marketing Pharma Companies Life Science 130

pharmaphorum

APRIL 19, 2022

Ehab graduated from Harvard Business school’s Executive General Management Programme in 2009 and holds a bachelor’s degree in Pharmaceutical Sciences. The post The largest pharma company in Europe calls for interoperability appeared first on. About the author .

Pharma Companies 111

Pharma Companies Life Science Clinical Research Research 111

pharmaphorum

MARCH 22, 2021

For the past year, life science companies around the world worked at breakneck speed to develop and manufacture safe and effective treatments to respond to the COVID-19 pandemic. India and China have seen the emergence of strong, local pharma companies. With India and China having populations of 1.3

Manufacturing 122

Manufacturing Marketing Vaccination Vaccine 122

XTalks

JANUARY 4, 2023

In this episode, Ayesha talked about some of the trends to look out for in the life sciences in 2023. Also hear about the issue of drug shortages and how pharma companies hope to tackle it in 2023. Read the full article here: 4 Life Sciences Trends for 2023.

Life Science 52

Life Science Gene Therapy Gene Pharma Companies 52

Pharmaceutical Technology

AUGUST 1, 2022

Before the Covid-19 pandemic, government-led investment and engagement in life sciences was relatively restricted worldwide, with the industry mostly funded via private investment. Many new therapeutics are needed to treat the broad range of bacterial infections, and bringing new antibiotics to market is both difficult and expensive.

Vaccination 234

Vaccination Vaccine Bacteria Life Science 234

pharmaphorum

MAY 24, 2022

Organisations are missing out on the ability to harness their data to energise precision marketing and transform commercial performance. The pharma industry is adjusting to massive upheaval from the pandemic and markets are emerging from its grip reshaped and alive with competition. Deeper Insights. Single View of HCPs.

Marketing 111

Marketing Sales Life Science Pharma Companies 111

pharmaphorum

JANUARY 10, 2023

Data is transforming life sciences, but many organisations are not using its full potential. Life sciences and the pharmaceutical industry are awash with data. Capturing market share. The combination of health and data, he passionately believes, will transform life sciences. billion in 2021 to $9.23

Marketing 98

Marketing Life Science Sales Branding 98

Delveinsight

JULY 21, 2021

However, some of the key pharma companies at the global level have shifted their focus towards these diverse diseases. Through this article, we have covered the major autoimmune diseases and the key companies striving to transform the treatment landscape of the respective disease. Multiple Sclerosis (MS).

Pharma Companies 94

Pharma Companies Marketing Development Insulin 94

XTalks

AUGUST 26, 2022

Full lifecycle recruitment can help life science and pharma companies find the best talent to fill job postings. Recruiters, HR leaders and leaders in the life sciences and pharma who manage people can benefit from using full lifecycle recruiting to enhance a life sciences organization’s hiring process.

Life Science 59

Life Science HR Sales Pharma Companies 59

Delveinsight

AUGUST 20, 2021

At present, there are several nonsurgical and surgical options in the Fecal Incontinence market. Conservative treatment approaches in the FI theraoy market include bulking agents and biofeedback. However, Biofeedback is the gold standard of the non-operative strategies in the FI therapeutics market.

Marketing 98

Marketing Pharma Companies Life Science Compliance 98

pharmaphorum

AUGUST 18, 2020

Pharma companies have improved how they engage with healthcare providers as a result of COVID-19, according to a new survey of HCPs. This has resulted in pharma companies being more relevant and providing more value in closing the care gap, the report says.

Pharma Companies 130

Pharma Companies Sales Life Science Marketing 130

XTalks

FEBRUARY 17, 2021

Moreover, AI has the power to fuel a broad reach, extending out into local, national and international markets to harness data from user profiles worldwide. By leveraging AI technology, organizations can cut the time spent on advertising on job boards, social media and manually going through resumes and profiles online.

Life Science 97

Life Science HR Clinical Research Clinical Trials 97

XTalks

DECEMBER 29, 2022

The life sciences and healthcare are among the biggest industries globally, and their significance was particularly highlighted during the past couple of years by the COVID-19 pandemic. Given the hyperfocus on the life sciences thanks to COVID, consumers appear to be more autonomous and vocal about their medical demands and choices.

Life Science 52

Life Science Gene Therapy Gene Manufacturing 52

pharmaphorum

JUNE 6, 2022

Eversana’s suite of commercialisation tools for pharma companies will soon have a new component – cognitive behavioural training tools designed to improve the performance of sales representatives. pic.twitter.com/MUKcXaganu. — Limitless Minds (@Thinkbig_gofar) July 25, 2019.

Sales 118

Sales Life Science Pharma Companies Marketing 118

World of DTC Marketing

JUNE 22, 2022

PBMs, insurers, pharma companies, and hospitals don’t want to give up their profits even if it’s better for the general population. The company has hired former senior health regulators to help it navigate America’s healthcare bureaucracy. .

Pharmacy 227

Pharmacy Generic Drugs Life Science Branding 227

pharmaphorum

AUGUST 17, 2020

N o one industry is ever quite like another, but there are some valuable lessons for pharma marketing from examining how the financial sector uses technology, builds brands on social channels and approaches digital content. Within this, the progressive pharma companies are utilising modular content to increase brand standards.

Regulation 97

Regulation Marketing Sales Branding 97

XTalks

OCTOBER 4, 2023

Health economics and outcomes research (HEOR) and market access strategies play a critical role in ensuring that newly approved therapies are made available to patients. Professionals in these roles are facing new challenges when it comes to negotiating coverage for many of the new, innovative treatments that are coming to market.

Marketing 105

Marketing Development Drugs Gene Therapy 105

pharmaphorum

FEBRUARY 11, 2021

If pharma companies are to live up to their decades-old patient-centric promises then marketing budgets need to move from brands and franchises to omnichannel customer-centric teams, according to one digital transformation leader. Pharma companies really need to become patient, but also healthcare professional, centric.

Pharma Companies 104

Pharma Companies Branding Marketing Life Science 104

pharmaphorum

DECEMBER 14, 2022

Last month we saw some movement in the pharma world, but also in some of the orbiting worlds of agencies, consultancies, and pharma investors. November saw the launch of a new private equity team in life sciences at J.P. Morgan Asset Management, dubbed Life Sciences Private Capital. New CEO joins UBC.

Life Science 98

Life Science Gene Therapy Gene Editing Gene 98

VirTrial

SEPTEMBER 21, 2020

The annual peer-reviewed awards program from the publisher of Fierce Biotech and Fierce Pharma highlights companies that have demonstrated innovative solutions, technologies, and services and have the potential to make the greatest impact for biotech and pharma companies.?. 2020 Accolades. About Fierce Innovation Awards.

Life Science 52

Life Science Clinical Research Coordinator Clinical Research Pharma Companies 52

pharmaphorum

JUNE 9, 2021

At Fishawack Health, we are always seeking opportunities to enhance our capabilities and help our life science clients navigate the new, dynamically changing healthcare environment. Meet closerlook. The COVID-19 pandemic has highlighted the necessity of digital communication and the opportunities an omnichannel approach brings.

Marketing 72

Marketing Life Science Branding Development 72

pharmaphorum

DECEMBER 7, 2021

Since the onset of the Covid-19 pandemic, life science companies have acted quickly to address the evolving digital needs of healthcare professionals, with mixed success (see graph 1). For the most part, life science companies have a relatively good knowledge of what their audiences want and need from them.

Life Science 105

Life Science Pharma Companies Branding Marketing 105

pharmaphorum

NOVEMBER 3, 2021

Pharma companies are producing and distributing more digital content than ever due to the pandemic, meaning the content presented needs to stand out in the crowded digital space to garner attention. Content metrics is the collection of data related to an industry or a company’s content. New content does not need to be rewritten.

Pharma Companies 98

Pharma Companies Life Science Marketing Branding 98

XTalks

DECEMBER 4, 2024

Jupiter Neurosciences, a clinical-stage pharma company specializing in neuroinflammation, made its public market debut with an initial public offering (IPO) on the Nasdaq Capital Market under the symbol “JUNS.” ” The company priced 2,750,000 shares of common stock at $4.00

Bioavailability 111

Bioavailability Genetic Disease Marketing RNA 111

pharmaphorum

MAY 13, 2021

Virtual communications between sales reps and HCPs jumped significantly during 2020, making it more important than ever for pharma companies to maintain up-to-date customer data. Rather than simply surviving, the life sciences industry needs to respond proactively. About Veeva Systems.

Life Science 105

Life Science Sales Pharma Companies Production 105

pharmaphorum

JANUARY 21, 2021

86% of respondents to a recent Veeva survey of pharma and biotech professionals said they are creating a greater volume of content now, compared to six months ago. To assist executives in life sciences with scaling marketing assets in a virtual world Veeva has published a new eBook, Powering Omnichannel Strategies with Modular Content.

Life Science 71

Life Science Marketing Sales Compliance 71

pharmaphorum

JANUARY 19, 2021

A new survey highlights the importance of customer reference data to digital transformation and analyses ways pharma companies can improve the quality of their datasets. More pharma companies are moving in this direction, and 78% of respondents said they are undertaking, or planning, a customer data enhancement initiative.

Sales 103

Sales Pharma Companies Life Science Production 103

pharmaphorum

NOVEMBER 30, 2022

Veeva Systems invited pharmaphorum to attend its industry summit in Madrid this week, a huge event that gathered together over 1,000 individuals from life sciences and pharma. The question is, how can the journey there be accelerated, when on the horizon awaits a life sciences future very much immersed in speciality medicine?

Life Science 98

Life Science Pharma Companies Sales Marketing 98

Pharmaceutical Technology

OCTOBER 28, 2022

While implemented to improve transparency and market competition, this new legislation has caused considerable upheaval for clinical trial providers. But if they’re doing that internally, they may have a bias, either because of a life sciences background or involvement in the clinical trial itself.

Clinical Trials 130

Clinical Trials Clinical Trials Life Science Trials 130

pharmaphorum

MARCH 9, 2021

Market pressures. Veeva highlights in the whitepaper that marketing and sales functions need to work closely together to deliver the right messages aligned with doctors’ real needs. Pharma needs to listen to what doctors are saying,” Noel says. Companies need to experiment with new ways of working and not be afraid to fail.

Sales 131

Sales Doctors Doctor Marketing 131

pharmaphorum

JANUARY 31, 2022

Creating personalised, compliant content is becoming increasingly important for life science companies as HCPs demand more from their digital content. Pharma companies created 3.5 Veeva is the global leader in cloud software for the life sciences industry. Download the whitepaper here: [link].

Marketing 52

Marketing Life Science Compliance Pharma Companies 52

Pharma Marketing Network

FEBRUARY 10, 2022

Experts from top life sciences companies discussed strategies for more effectively engaging oncologists at the Pharma Marketing Network’s 2022 Future Forecast on January 25 th. Pharma marketers need to educate oncologists on available treatment options that keep up with the constant updates to standards of care. “In

Branding 98

Branding Marketing Life Science Pharma Companies 98

XTalks

MAY 20, 2021

In this episode, Ayesha discusses the latest trends in pharma tv ad spending, including the top spenders last week. The pandemic has led to a rise in both TV watching and health awareness, which pharma companies took advantage of by increasing spending on TV commercials by about 17 percent overall.

Life Science 40

Life Science Pharma Companies Development Drugs 40

Pharmaceutical Technology

FEBRUARY 13, 2023

SK Life Science is a subsidiary of SK, a South Korean holding company. In October 2022, mjn-neuro signed a commercialization agreement with the pharma company Neuraxpharm Group to market mjn-SERAS. There is also an interest in repurposed treatments such as Fintepla for rare diseases, says Carney.

Research 264

Research Gene Gene Therapy Genomics 264

pharmaphorum

OCTOBER 19, 2022

Emma Hyland, VP strategy, commercial content at Veeva Systems, tells us modular content is the most significant wave of innovation hitting the content world in life sciences, and rightly so because HCPs’ needs and expectations have changed. “There isn’t a one-size-fits-all for how the life sciences industry creates content.

Life Science 97

Life Science Compliance Production Pharma Companies 97